HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joanna Jakubowicz-Gil Selected Research

7-hydroxycoumarin (umbelliferone)

11/2020Antiglioma Potential of Coumarins Combined with Sorafenib.
8/2020Coumarins modulate the anti-glioma properties of temozolomide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joanna Jakubowicz-Gil Research Topics

Disease

11Glioma (Gliomas)
01/2022 - 10/2010
11Astrocytoma (Pilocytic Astrocytoma)
01/2022 - 10/2010
10Glioblastoma (Glioblastoma Multiforme)
01/2022 - 08/2013
9Necrosis
01/2022 - 01/2008
8Neoplasms (Cancer)
01/2022 - 04/2010
4Hyperthermia
01/2005 - 01/2002
3Carcinoma (Carcinomatosis)
07/2014 - 12/2009
2Brain Neoplasms (Brain Tumor)
08/2020 - 08/2017
2Colonic Neoplasms (Colon Cancer)
10/2016 - 04/2010
2Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2002 - 01/2002
2Lung Neoplasms (Lung Cancer)
01/2002 - 01/2002
2Laryngeal Neoplasms (Laryngeal Cancer)
01/2002 - 01/2002
1B-Cell Lymphoma (Lymphoma, B Cell)
11/2020
1Fibrosarcoma
11/2020
1Phototoxic Dermatitis (Phototoxicity)
04/2020
1Prostatic Neoplasms (Prostate Cancer)
01/2020
1Neoplasm Metastasis (Metastasis)
04/2010
1Neuroblastoma
01/2008

Drug/Important Bio-Agent (IBA)

12QuercetinIBA
07/2014 - 01/2002
7Temozolomide (Temodar)FDA LinkGeneric
05/2021 - 10/2010
5Proteins (Proteins, Gene)FDA Link
04/2010 - 01/2002
4Sorafenib (BAY 43-9006)FDA Link
05/2021 - 07/2014
3CoumarinsIBA
11/2020 - 04/2020
3imperatorinIBA
07/2014 - 10/2012
3Cisplatin (Platino)FDA LinkGeneric
10/2012 - 01/2002
2Biological ProductsIBA
01/2022 - 10/2016
2osthol (osthole)IBA
11/2020 - 08/2020
2Esculin (Aesculin)IBA
11/2020 - 08/2020
27-hydroxycoumarin (umbelliferone)IBA
11/2020 - 08/2020
2Caspase 3 (Caspase-3)IBA
08/2020 - 01/2008
2FlavonoidsIBA
10/2010 - 01/2008
2Heat-Shock Proteins (Heat-Shock Protein)IBA
04/2010 - 12/2009
2Etoposide (VP 16)FDA LinkGeneric
01/2002 - 01/2002
2Molecular Chaperones (Chaperone, Molecular)IBA
01/2002 - 01/2002
1EstersIBA
01/2022
1AlcoholsIBA
01/2022
1Terpenes (Terpenoids)IBA
01/2022
1Matrix Metalloproteinases (MMPs)IBA
05/2021
1raf KinasesIBA
05/2021
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
05/2021
1Small Interfering RNA (siRNA)IBA
11/2020
1Fluorescent Dyes (Fluorescent Probes)IBA
11/2020
1Phosphotransferases (Kinase)IBA
11/2020
14-hydroxycoumarinIBA
08/2020
1Beclin-1IBA
08/2020
1Furocoumarins (Furanocoumarins)IBA
04/2020
12,5-dimethoxy-p-cymeneIBA
03/2020
1Ether (Diethyl Ether)IBA
03/2020
1ThymolIBA
03/2020
1Volatile Oils (Essential Oils)IBA
11/2019
1Neprilysin (Neutral Endopeptidase)IBA
10/2016
1EndopeptidasesIBA
10/2016
1Drug CombinationsIBA
01/2011
1Pharmaceutical PreparationsIBA
10/2010
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
04/2010
1CamptothecinIBA
04/2010
1Irinotecan (Camptosar)FDA LinkGeneric
04/2010
1Interleukin-1beta (Interleukin 1 beta)IBA
04/2010
1Antisense OligonucleotidesIBA
01/2008
1bisbenzimide ethoxide trihydrochloride (Hoechst 33342)IBA
01/2008
1Propidium (Propidium Iodide)IBA
01/2008
1HSP72 Heat-Shock ProteinsIBA
01/2002
1HSP27 Heat-Shock ProteinsIBA
01/2002

Therapy/Procedure

7Therapeutics
05/2021 - 04/2010
5Drug Therapy (Chemotherapy)
01/2022 - 04/2010
1Immunotherapy
01/2020
1Radiotherapy
01/2020
1Aftercare (After-Treatment)
01/2008